Ubs Group Ag Kiniksa Pharmaceuticals, Ltd. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$17.63 - $21.74 $341,069 - $420,582
19,346 Added 22.65%
104,762 $2.07 Million
Q4 2023

Feb 09, 2024
BUY
$14.37 - $19.07 $324,790 - $431,020
22,602 Added 35.98%
85,416 $1.5 Million
Q3 2023

Nov 09, 2023
BUY
$13.62 - $20.2 $247,489 - $367,054
18,171 Added 40.7%
62,814 $1.09 Million
Q2 2023

Aug 11, 2023
SELL
$10.44 - $16.48 $69,655 - $109,954
-6,672 Reduced 13.0%
44,643 $628,000
Q1 2023

May 12, 2023
SELL
$10.7 - $15.79 $61,952 - $91,424
-5,790 Reduced 10.14%
51,315 $552,000
Q4 2022

Feb 08, 2023
BUY
$11.42 - $17.05 $652,139 - $973,640
57,105 New
57,105 $855,000
Q2 2022

Aug 10, 2022
SELL
$7.6 - $11.41 $8,914 - $13,383
-1,173 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$9.3 - $12.37 $700,308 - $931,485
-75,302 Reduced 98.47%
1,173 $12,000
Q4 2021

Feb 14, 2022
SELL
$10.39 - $15.15 $65,062 - $94,869
-6,262 Reduced 7.57%
76,475 $900,000
Q3 2021

Nov 15, 2021
BUY
$11.39 - $16.23 $714,358 - $1.02 Million
62,718 Added 313.29%
82,737 $942,000
Q2 2021

Aug 13, 2021
SELL
$13.22 - $19.09 $206,549 - $298,262
-15,624 Reduced 43.83%
20,019 $279,000
Q1 2021

May 12, 2021
BUY
$16.68 - $23.97 $571,723 - $821,595
34,276 Added 2507.39%
35,643 $660,000
Q4 2020

Feb 11, 2021
SELL
$14.8 - $21.15 $16,916 - $24,174
-1,143 Reduced 45.54%
1,367 $24,000
Q3 2020

Nov 12, 2020
SELL
$15.21 - $25.53 $123,824 - $207,839
-8,141 Reduced 76.43%
2,510 $38,000
Q2 2020

Jul 31, 2020
BUY
$15.08 - $26.0 $51,890 - $89,466
3,441 Added 47.73%
10,651 $271,000
Q1 2020

May 01, 2020
SELL
$11.0 - $19.76 $129,338 - $232,338
-11,758 Reduced 61.99%
7,210 $112,000
Q4 2019

Feb 14, 2020
BUY
$5.24 - $12.96 $50,324 - $124,467
9,604 Added 102.56%
18,968 $210,000
Q3 2019

Nov 14, 2019
BUY
$8.15 - $15.88 $62,176 - $121,148
7,629 Added 439.71%
9,364 $80,000
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.39 $22,902 - $35,376
1,735 New
1,735 $23,000
Q4 2018

Feb 14, 2019
SELL
$16.25 - $28.09 $24,862 - $42,977
-1,530 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$13.23 - $30.93 $20,241 - $47,322
1,530 New
1,530 $39,000

Others Institutions Holding KNSA

# of Institutions
9
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $951M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email